Allergen News and Research

RSS
One in five children have eczema

One in five children have eczema

New type of yogurt fights bacteria that cause gastritis and stomach ulcers

New type of yogurt fights bacteria that cause gastritis and stomach ulcers

Children can complete treatment for peanut allergies and achieve long-term tolerance

Children can complete treatment for peanut allergies and achieve long-term tolerance

A vaccine for multiple sclerosis

A vaccine for multiple sclerosis

Emerging therapies could ease symptoms of Atopic dermatitis

Emerging therapies could ease symptoms of Atopic dermatitis

Aerovance starts trial of Aerovant for uncontrolled asthma

Aerovance starts trial of Aerovant for uncontrolled asthma

Airborne microbial fungi linked to asthma

Airborne microbial fungi linked to asthma

Babies born in pollen and mold seasons have increased likelihood of wheezing by age two

Babies born in pollen and mold seasons have increased likelihood of wheezing by age two

Researchers 'tighten' body's protective coating

Researchers 'tighten' body's protective coating

Natural aromatic oils may cause allergies

Natural aromatic oils may cause allergies

Most Australian food recalls due to 'foreign matter'

Most Australian food recalls due to 'foreign matter'

Reasons behind the South's higher stroke death rate

Reasons behind the South's higher stroke death rate

Expert says gross over-reaction to peanuts to blame for 'nut hysteria'

Expert says gross over-reaction to peanuts to blame for 'nut hysteria'

Lupin allergy in children

Lupin allergy in children

New European food allergy research

New European food allergy research

New advances in diagnosis and treatment of allergic diseases

New advances in diagnosis and treatment of allergic diseases

Food allergies are on the rise but effective treatment in the pipeline

Food allergies are on the rise but effective treatment in the pipeline

Xolair (Omalizumab) shows promise in treating allergic asthma inadequately controlled by inhaled corticosteroid

Xolair (Omalizumab) shows promise in treating allergic asthma inadequately controlled by inhaled corticosteroid

Dermatitis management

Dermatitis management

Efficacy, dosage concerns unresolved on sublingual immunotherapy

Efficacy, dosage concerns unresolved on sublingual immunotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.